Sifting Active Pharmaceutical Ingredients

Cipla gives seal of approval for OEL level 5 screener

When processing active pharmaceutical ingredients (API’s), the occupational exposure limit (OEL) has a significant part to play in the design of a process to ensure operators are not at risk to exposure. Therefore when Cipla Ltd built their OEL compliant plant at their Goa factory in 2005, having a screener that would ensure product quality and integrity were maintained without compromising the safety of their operators was essential. In search for a suitable screener to remove any oversized contamination from their incoming raw materials and to remove undersized particulates after granulation, Cipla attended an exhibition and came across the OEL level 5 compliant Russell Compact Airlock Sieve™.

Screening active pharmaceutical ingredients

The sieve utilizes a pneumatic clamping system, which, combined with its patented Twist Lock Inflate (TLI) technology, provides a uniform dust tight seal. Assembly and dis-assembly of the sieve is achieved in seconds. The component parts are placed into the base and located by twisting and locking the lid without the need for tools. The airclamp is then inflated to secure and seal the unit during operation. The unit is suitable for either continuous or batch operations and also lends itself to applications where a number of different products are being processed due to the simplicity and speed with which it can be dis-assembled and cleaned.

Read more about: Processing Active Pharmaceutical ingredients

Recommended products

View more Products

What our clients say

“During initial product trials, we recognized how the new Airlock screener utilizes the Russell Compact technology to increase screening efficiency allowing even sticky products to be sieved without blinding. Also, due to its new clamping system, it is extremely easy to dismantle when compared to conventional clamping methods. It is clear that this particular unit has been designed specifically for this type of application.”
Tapas Datta, Cipla

Back to Case Studies